Contents contributed and discussions participated by Matthew Links
EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retr... - 0 views
SpringerLink - Journal Article - 0 views
NEJM -- Oncogenes and Cancer - 0 views
‹ Previous
21 - 40 of 59
Next ›
Showing 20▼ items per page